TPG Closes Inaugural Life Sciences Fund at $580M

Focuses on Advancing Biopharmaceutical Innovation

TPG has completed fundraising for its first life sciences fund, securing $580 million in commitments. The fund will focus on investments in biopharmaceutical companies, aiming to accelerate drug development and medical innovation. Based in San Francisco and Fort Worth, TPG is targeting high-growth companies within the life sciences sector, leveraging its extensive healthcare expertise. This marks the firm’s continued push into sector-specific funds, following successful capital raises in healthcare and technology-focused funds.